MFAP4 deficiency alleviates renal fibrosis through inhibition of NF-κB and TGF-β/Smad signaling pathways. 2020

Zhou Pan, and Kang Yang, and Huibo Wang, and Yusha Xiao, and Ming Zhang, and Xi Yu, and Tao Xu, and Tao Bai, and Hengcheng Zhu
Department of Urology, Renmin Hospital of Wuhan University, Wuhan, P.R. China.

Renal fibrosis, which is characterized by excessive extracellular matrix (ECM) accumulation in the renal tubulointerstitium, can lead to chronic kidney disease (CKD). The role of microfiber-associated protein 4 (MFAP4), which is an ECM protein that interacts with elastin and collagen, in renal fibrosis has not been investigated. The aim of this study was to examine the role of MFAP4 in the pathogenesis of renal fibrosis and the underlying mechanism using in vivo and in vitro models. The MFAP4-/- mice were subjected to unilateral ureteral obstruction (UUO) to elucidate the role of MFAP4 in renal fibrosis in vivo. Compared to the wild-type mice, the MFAP4-/- mice exhibited decreased protein expression of p-p65 and p-IKBα and ECM deposition after UUO. The MFAP4-/- mice exhibited attenuated nuclear translocation of p65 (the hub subunit of nuclear factor (NF)-κB signaling pathway), suppressed activation of transforming growth factor (TGF)-β/Smad pathways, and downregulated expression of fibronectin, collagen I, and plasminogen activator inhibitor-1. The knockdown of MFAP4 mitigated the TGF-β-induced upregulated expression of fibronectin, collagen I, and plasminogen activator inhibitor-1 in the human proximal tubular epithelial cells (HK-2). Compared to the HK-2 cells transfected with sh-MFAP4, the HK-2 cells co-transfected with sh-MFAP4 and Ad-MFAP4 exhibited severe inflammatory response and increased fibrosis-related proteins expression. Mechanistically, the knockdown of MFAP4 inhibited the activation of NF-κB and TGF-β/Smad signaling pathways and downregulated the expression of fibrosis-related proteins. The findings of this study indicate that MFAP4 is involved in UUO-induced renal fibrosis through regulation of NF-κB and TGF-β/Smad pathways.

UI MeSH Term Description Entries
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005353 Fibronectins Glycoproteins found on the surfaces of cells, particularly in fibrillar structures. The proteins are lost or reduced when these cells undergo viral or chemical transformation. They are highly susceptible to proteolysis and are substrates for activated blood coagulation factor VIII. The forms present in plasma are called cold-insoluble globulins. Cold-Insoluble Globulins,LETS Proteins,Fibronectin,Opsonic Glycoprotein,Opsonic alpha(2)SB Glycoprotein,alpha 2-Surface Binding Glycoprotein,Cold Insoluble Globulins,Globulins, Cold-Insoluble,Glycoprotein, Opsonic,Proteins, LETS,alpha 2 Surface Binding Glycoprotein
D005355 Fibrosis Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury. Cirrhosis,Fibroses
D006023 Glycoproteins Conjugated protein-carbohydrate compounds including MUCINS; mucoid, and AMYLOID glycoproteins. C-Glycosylated Proteins,Glycosylated Protein,Glycosylated Proteins,N-Glycosylated Proteins,O-Glycosylated Proteins,Glycoprotein,Neoglycoproteins,Protein, Glycosylated,Proteins, C-Glycosylated,Proteins, Glycosylated,Proteins, N-Glycosylated,Proteins, O-Glycosylated
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014517 Ureteral Obstruction Blockage in any part of the URETER causing obstruction of urine flow from the kidney to the URINARY BLADDER. The obstruction may be congenital, acquired, unilateral, bilateral, complete, partial, acute, or chronic. Depending on the degree and duration of the obstruction, clinical features vary greatly such as HYDRONEPHROSIS and obstructive nephropathy. Obstruction, Ureteral,Obstructions, Ureteral,Ureteral Obstructions

Related Publications

Zhou Pan, and Kang Yang, and Huibo Wang, and Yusha Xiao, and Ming Zhang, and Xi Yu, and Tao Xu, and Tao Bai, and Hengcheng Zhu
May 2020, Journal of cellular and molecular medicine,
Zhou Pan, and Kang Yang, and Huibo Wang, and Yusha Xiao, and Ming Zhang, and Xi Yu, and Tao Xu, and Tao Bai, and Hengcheng Zhu
August 2023, Cellular signalling,
Zhou Pan, and Kang Yang, and Huibo Wang, and Yusha Xiao, and Ming Zhang, and Xi Yu, and Tao Xu, and Tao Bai, and Hengcheng Zhu
February 2018, International immunopharmacology,
Zhou Pan, and Kang Yang, and Huibo Wang, and Yusha Xiao, and Ming Zhang, and Xi Yu, and Tao Xu, and Tao Bai, and Hengcheng Zhu
December 2022, Laboratory investigation; a journal of technical methods and pathology,
Zhou Pan, and Kang Yang, and Huibo Wang, and Yusha Xiao, and Ming Zhang, and Xi Yu, and Tao Xu, and Tao Bai, and Hengcheng Zhu
January 2021, Journal of ophthalmology,
Zhou Pan, and Kang Yang, and Huibo Wang, and Yusha Xiao, and Ming Zhang, and Xi Yu, and Tao Xu, and Tao Bai, and Hengcheng Zhu
January 2022, BioMed research international,
Zhou Pan, and Kang Yang, and Huibo Wang, and Yusha Xiao, and Ming Zhang, and Xi Yu, and Tao Xu, and Tao Bai, and Hengcheng Zhu
January 2018, Journal of ethnopharmacology,
Zhou Pan, and Kang Yang, and Huibo Wang, and Yusha Xiao, and Ming Zhang, and Xi Yu, and Tao Xu, and Tao Bai, and Hengcheng Zhu
January 2015, Frontiers in physiology,
Zhou Pan, and Kang Yang, and Huibo Wang, and Yusha Xiao, and Ming Zhang, and Xi Yu, and Tao Xu, and Tao Bai, and Hengcheng Zhu
January 2020, International immunopharmacology,
Zhou Pan, and Kang Yang, and Huibo Wang, and Yusha Xiao, and Ming Zhang, and Xi Yu, and Tao Xu, and Tao Bai, and Hengcheng Zhu
September 2023, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!